Anthony Mirhaydari

InvestorPlace Market Strategist

Anthony Mirhaydari is founder of the Edge and Edge Pro investment advisory newsletters.

He is an independent investment columnist with work appearing at Investorplace, The Fiscal Times, CBS News MoneyWatch, MSN Money, Yahoo Finance, and Dow Jones MarketWatch. He started covering the markets and the economy in the media in 2008 in the midst of the greatest financial crisis in generations.

Previously, he was a senior research analyst with Markman Capital Insight, an advisory and money management firm, and a business consulting analyst with Moss Adams focusing on the financial-services industry.

Recent Articles

Wall Street Bears Brunt of Disappointing Black Friday

By Anthony Mirhaydari, InvestorPlace Market Strategist Nov 30, 2015

Stocks waned Monday in the wake of disappointing Black Friday turnout, with energy leading the way and health care picking up the rear. For the week ahead, investors look forward to the OPEC conference and Friday's payroll report.

Divergences Grow as Stocks Flatline

By Anthony Mirhaydari, InvestorPlace Market Strategist Nov 25, 2015

Stocks finished mixed on Wednesday, but there's growing evidence of a withdrawal of risk appetites as equities disconnect from weakness in the commodities and fixed-income markets.

5 Big Bank Stocks to Sell on Rate Hike Fears

By Anthony Mirhaydari, InvestorPlace Market Strategist Nov 25, 2015

These five bank stocks could be the victims of a Fed policy mistake, as increasing deflation/slowdown fears could lower long-term rates.

Stocks Shake off Russia-Syria Headlines

By Anthony Mirhaydari, InvestorPlace Market Strategist Nov 24, 2015

With markets closed on Thursday, trading volumes are likely to be light on Wednesday amid a flurry of economic data releases including personal income and outlays, durable goods orders and jobless claims.

Wall Street Slides Lower in Pre-Holiday Trading

By Anthony Mirhaydari, InvestorPlace Market Strategist Nov 23, 2015

Stocks moved lower on Wall Street today, with consumer staples leading the way and telecom bringing up the rear. Crude saw some overnight volatility, while Pfizer made headlines with an inversion deal with Allergan.